# Indivior Pharmaceuticals, Inc. (INDV) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Indivior Pharmaceuticals, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/INDV/mda/fy2025/): filed 2026-02-26; accession 0001628280-26-012237 (https://www.sec.gov/Archives/edgar/data/1625297/000162828026012237/indv-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/INDV/mda/fy2024/): filed 2025-03-03; accession 0001625297-25-000016 (https://www.sec.gov/Archives/edgar/data/1625297/000162529725000016/indv-20241231.htm)

Back to /company/INDV/